about
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Bioengineered Temporomandibular Joint Disk Implants: Study Protocol for a Two-Phase Exploratory Randomized Preclinical Pilot Trial in 18 Black Merino Sheep (TEMPOJIMS).Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise.Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis.Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.The impact of dosing frequency on medication adherence in chronic cardiovascular disease: systematic review and meta-analysis.Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis.The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies.How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis.Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants: Systematic Review and Meta-analysis.Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis.Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants.Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysisBranded versus generic clopidogrel in cardiovascular diseases: a systematic review.Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies.Cochrane Corner: evaluation of the Cochrane systematic review "antiplatelet agents for chronic kidney disease".Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis.Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs.Oral anticoagulation for pulmonary arterial hypertension: systematic review and meta-analysis.Cochrane Corner: What is the clinical impact of oxygen therapy for acute myocardial infarction? Evaluation of a Cochrane systematic review.Cochrane Corner: Corticosteroids for viral myocarditis.Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis.Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis.Cochrane Corner: Colchicine in acute and recurrent pericarditis.Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis.Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.Safety of non-vitamin K antagonist oral anticoagulants - coronary risks.Accuracy of diagnostic tests for Legionnaires' disease: a systematic review.Are there effective interventions to prevent hospital-acquired Legionnaires' disease or to reduce environmental reservoirs of Legionella in hospitals? A systematic review.Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in Portugal.Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?[Analysis of the Cochrane Review: Influenza Vaccines for Preventing Cardiovascular Disease. Cochrane Database Syst Rev. 2015;5:CD005050].Burden of disease and cost of illness of atrial fibrillation in Portugal.Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: a meta-analysis.[What is the benefit of salt reduction on blood pressure? Assessment of the Cochrane Review: Effect of longer-term modest salt reduction on blood pressure. He FJ, Li J, Macgregor GA. Cochrane Database Syst Rev. 2013 Apr 30;4:CD004937].Novel Antithrombotic Drugs and Intraocular Bleeding: The Importance of Observational Data and Future Perspectives.
P50
Q26752659-C5C67EFF-61D0-4AA4-851B-C6A96C934DFFQ27690881-EF4A270F-85DA-40C8-B259-7B11148AD908Q30360299-79DF0F8F-2C54-4248-B0D7-294A0EA63109Q30451775-F050B27B-74E0-4C28-9324-F1BDA24EB8D1Q33782882-E0CBEFEC-C00E-4A33-B230-7113BF4DB8E3Q34967540-C8D90CC8-8020-46E6-BD51-1B1AC88CBD9AQ35205072-23C28F0D-469E-486A-B4B1-75A6304D1F1FQ35214622-FC346406-B510-4FB4-A9DE-27B8B67D75CDQ35224171-722E997C-E0B1-4066-86D6-8AF3A65B1BA7Q35266904-6C440887-4D09-493B-822A-9564ECFC766EQ35471278-01765681-9E67-420F-AD48-AACCB42056D2Q35553820-AE3B5844-D5FA-4982-91BD-E2E57738D2B1Q35624075-B45CAFE9-6DD5-4B24-8D76-62528378C648Q35640960-5D8DEF60-6CDC-4762-BC6F-7A7CB5F659B9Q35650348-DA42BD54-CF67-4AA1-AF91-208DEF72B4AEQ35798597-5286B2F2-DAED-4501-9552-BF2A62E4371CQ36089280-25D4313B-3DD5-43F3-9B9D-87AD51B6093DQ38063135-8AB3511D-0659-477F-B9F1-156A4C026764Q38134700-FBAA8748-6EB5-47DE-A75F-CD9AD7014616Q38165552-058CE359-C2D1-40AD-88AC-B7C1635B160DQ38183208-BF0EF4C2-E240-46A4-9495-1EF953D09846Q38198567-A00AFE8D-51C2-48AB-8FC3-EA00C56D0B38Q38225415-52734126-93AA-45B9-B115-F16828F6C99AQ38259065-9650D6E8-6BAD-4A92-9FA2-E617E882E2B4Q38295715-8B669297-0C76-4250-A8EA-768588D22B37Q38331661-FBBE596D-8713-4B3B-AE4C-03B00DCE3636Q38532303-4E70729C-6D94-481D-A557-61B7C810DA40Q38617670-CDE9D222-AB34-4F22-8035-787EB65053E4Q38635488-4A51A478-65B8-4A1D-99FB-9885CA4D064CQ38744960-DAEA1CA4-FF26-4109-8EC0-22AFBF061525Q38766678-7AA42496-BA22-4DA1-9279-50CA1B1427A8Q38809071-4F7B4D1E-03BA-4826-AFF6-FDB2A2AC32B1Q38927621-1BB30698-256D-45F1-87F9-60DD619B5998Q40264196-B7DED3AE-59C1-4679-AC17-A94953AC19A0Q40826994-38DB1553-B0E9-4B17-9E87-2D870347F86EQ40907586-D9422501-6DC9-478B-B17F-42FA729B70F7Q41656691-052C50DE-66FA-4DE5-86FF-C08DC0004EC0Q45155989-535AC781-40A2-4BAE-809F-D5EB3F88977EQ45734425-8253D379-E4C5-4D69-8CCE-E2513FF1D6D4Q47306420-7D6770A0-30DE-4E02-B9D6-CDA2A84EAF27
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniel Caldeira
@ast
Daniel Caldeira
@en
Daniel Caldeira
@es
Daniel Caldeira
@nl
Daniel Caldeira
@sl
type
label
Daniel Caldeira
@ast
Daniel Caldeira
@en
Daniel Caldeira
@es
Daniel Caldeira
@nl
Daniel Caldeira
@sl
prefLabel
Daniel Caldeira
@ast
Daniel Caldeira
@en
Daniel Caldeira
@es
Daniel Caldeira
@nl
Daniel Caldeira
@sl
P106
P1153
36623384200
P21
P31
P496
0000-0002-2520-5673